RB

Renu Bansal

Active Director Director DIN 05302195
DIN 05302195 First appointment Jun 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2012
Shareholding value •••• Premium profile

About Renu Bansal

Data last updated:

Renu Bansal is a Director at Ashirwad Meditech Private Limited (since 2012). The company operates in Healthcare. Ashirwad Meditech Private Limited reported revenue of ₹1.76 Cr (FY 2025).

DIN 05302195
Primary Designation Director
Industry Healthcare
First Appointment 18 Jun 2012
Oldest Company Age 14 yrs
Largest company Ashirwad Meditech Private Limited · ₹1.76 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ashirwad Meditech Private Limited U93030UP2012PTC051042
Director18 Jun 20122012₹1.76 Cr (FY 2025)Active

Board colleagues of Renu Bansal

Directorship timeline

Open interactive timeline →
Ashirwad Meditech Private Limited
Premium access

Shareholding and investment profile for Renu Bansal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu Bansal

Renu Bansal currently holds 1 directorship: Ashirwad Meditech Private Limited (Director, since 18 Jun 2012, revenue ₹1.76 Cr (FY 2025)).

Renu Bansal was first appointed on 18 Jun 2012 as Director at Ashirwad Meditech Private Limited.

The current boards of Renu Bansal's companies include Dushyant Bansal (Ashirwad Meditech Private Limited), Nishkarsh Bansal (Ashirwad Meditech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available